Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial-Reference-Cited by-同舟云学术

Psychosocial morbidity in women with abnormal cervical cytology managed by cytological surveillance or initial colposcopy: longitudinal analysis from the TOMBOLA randomised trial

Published:2016-06-14 Issue:4 Volume:26 Page:476-483
ISSN:1057-9249
Container-title:Psycho-Oncology
language:en
Short-container-title:Psycho-Oncology

Author:

Fielding S.¹,Rothnie K.²,Gray N. M.³,Little J.⁴,Cruickshank M. E.⁵,Neal K.⁶,Walker L. G.⁷,Whynes D.⁸,Cotton S. C.⁹,Sharp L.¹⁰,

Affiliation:

1. Medical Statistics Team, Division of Applied Health Sciences; University of Aberdeen; Aberdeen Scotland

2. Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine and Faculty of Medicine; Imperial College London; London UK

3. Scottish Improvement Science Collaborating Centre, School of Nursing and Health Sciences; University of Dundee; Dundee Scotland

4. School of Epidemiology, Public Health and Preventive Medicine; University of Ottawa; Ottawa Canada

5. Division of Medical and Dental Education; University of Aberdeen; Aberdeen Scotland

6. Consultant Epidemiologist; London and South East PHE Centres; London UK

7. Medical Research Centre; University of Hull; Hull UK

8. School of Economics; University of Nottingham; Nottingham UK

9. Division of Applied Health Sciences; University of Aberdeen; Aberdeen UK

10. Institute of Health & Society; Newcastle University; Newcastle UK

Publisher

Wiley

Subject

Psychiatry and Mental health,Oncology,Experimental and Cognitive Psychology

Reference34 articles.

1. Cervical screening: a guideline for clinical practice in Ontario;Murphy;J Obstet Gynaecol Can,2012

2. World Health Organization WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention http://apps.who.int/iris/bitstream/10665/94830/1/9789241548694_eng.pdf

3. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance;Huh;Obstet Gynecol,2015

4. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1;Jordan;Cytopathology,2008

5. Emotional impact of screening: a systematic review and meta-analysis;Collins;BMC Public Health,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of colposcopy counseling with a feminist model on anxiety in Thai women with abnormal cervical cytology results: A time-series quasi-experimental study;Belitung Nursing Journal;2023-12-20

2. The Impact of HPV Diagnosis and the Electrosurgical Excision Procedure (LEEP) on Mental Health and Sexual Functioning: A Systematic Review;Cancers;2023-04-10

3. Adherence to follow‐up after the exit cervical cancer screening test at age 60–64: A nationwide register‐based study;Cancer Medicine;2021-11-12

4. Psychosocial impact of inclusion of HPV test on the management of women with atypical squamous cells of undetermined significance: a study within a randomised pragmatic trial in a middle-income country;Psychology & Health;2019-10-18

5. Impact of different educational interventions on psychosocial well-being of women with a positive high-risk human papillomavirus and normal cervical cytology: a randomised trial;Journal of Psychosomatic Obstetrics & Gynecology;2017-04-10